Case Report
BibTex RIS Cite

Rare reason of restrictive cardiomiyopathy: Hydraadenitis suppuritiva

Year 2020, Volume: 11 Issue: 5, 455 - 458, 30.12.2020
https://doi.org/10.18663/tjcl.737335

Abstract

In this case, a case of hydraadenitis suppuritiva (HS) with restrictive diastolic dysfunction and nephrotic syndrome is described. A 46-year-old male patient was hospitalized to cardiology clinic with non-ST elevation myocardial infarction, decompensated heart failure, acute renal failure and new diagnosis of diabetes mellitus. A nodular-cystic lesion in the chest, gluteal and axillary regions of the patient was found to be compatible with HS for one year. Grade 3 diastolic dysfunction (restrictive diastolic dysfunction) was found to echocardiographic examination of patient. The desired serum amyloid A was 120 mg / l (N: 0-6,4) considering systemic amyloidosis in patient with restrictive cardiomyopathy and nephrotic syndrome,. There were no evidence of monoclonal gammopathy in serum and urine protein electrophoresis. Secondary amylodosis and restrictive cardiomyopathy due to hydradenitis suppurativa was diagnosed. Secondary amyloidosis which has been investigated because of restrictive cardiomyopathy and nephrotic syndrome a rare complication of HS. Secondary amyloidosis which are associated with chronic diseases, should be considered in patients with small ventricular volume with thick walls accompanying diastolic dysfunction in cardiology clinics.

References

  • 1. Girouard, SD, Falk RH, Rennke, HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: A case report and review of the literature. Dermatology Online Journal 2012; 18: 2
  • 2.Ilgen U, Çelebi ZK., Kuzu I, Kutlay S, Nergizoglu G, Ates K. Renal amyloidosis secondary to hidradenitis suppurativa. Clinical Kidney Journal 2013; 6: 667–8.
  • 3.Montes-Romero JA, Callejas-Rubio JL, Sanchez-Cano D, Gonzalez-Martínez FJ, Navas-Parejo A, Ortego-Centeno N. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab. European Journal of Internal Medicine 2018; 19: 32–3.
  • 4.Fernandez-Nebro A, Alejandro O, Castro MC et al. Long-term TNFalfa blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. The American Journal of Medicine 2010; 123: 454–61.
  • 5. Pinney JH, Smith CJ, Taube JB et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol 2013; 161: 525-32.
  • 6. Schandorff KD, Miller IM, Krustrup D, Jemec GB, Marckmann P. Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa. Clinical Nephrology 2016; 86: 51 –4.
  • 7. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. The New England journal of medicine 2007; 356: 2361-71.
  • 8. Castano A, Narotsky DL, Hamid N et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 2017; 38: 2879–87.

Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa

Year 2020, Volume: 11 Issue: 5, 455 - 458, 30.12.2020
https://doi.org/10.18663/tjcl.737335

Abstract

Bu vakada restriktif diyastolik disfonksiyon, nefrotik sendrom ile seyreden bir hidraadenitis suppuritiva (HS) olgusu anlatılacaktır. 46 yaş daha önceden bilinen bir hastalığı olmayan erkek hasta kliniğimize ST elevasyonsuz miyokard infarktüsü, dekompanse kalp yetersizliği, akut böbrek yetersizliği, yeni tanı diyabetes mellitus ön tanılarıyla interne edildi. Hastanın göğüs, gluteal ve aksiller bölgede bir yıldır mevcut HS ile uyumlu nodüler-kistik bir lezyon saptandı. Hastanın ekokardiyografisi grade 3 diyastolik disfonksiyon (restriktif diyastolik disfonksiyon)” ile uyumlu saptandı. Restriktif kardiyomiyopatisi ve nefrotik sendromu olan hastada amiloidoz ön tanısı ile serum amiloid A düzeyi istendi, 120 mg/l (N:0-6.4) bulundu. Restriktif kardiyomiyopatisi ve nefrotik sendromu olan hastada amiloidoz ön tanısı ile serum amiloid A düzeyi istendi, 120 mg/l (N:0-6.4) bulundu. Serum ve idrar proteini elektroforezinde monoklonal gammopati kanıtı bulunamadı. Hidradenitis suppurativaya bağlı sekonder amilodoz ve restriktif kardiyomiyopati tanısı konuldu. Vakamız restriktif kardiyomiyopati olması üzerine araştırılan HS’ye sekonder, sekonder amiloidoz tanısı konulan bir vaka örneği olması nedeniyle özelliklidir. Kronik hastalıklarla birliktelik gösteren sekonder amiloidoz kardiyoloji kliniklerinde diyastolik disfonksiyona eşlik eden kalın duvarlarla birlikte küçük ventrikül hacmi olan hastalarda akla gelmelidir.

References

  • 1. Girouard, SD, Falk RH, Rennke, HG, Merola JF. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: A case report and review of the literature. Dermatology Online Journal 2012; 18: 2
  • 2.Ilgen U, Çelebi ZK., Kuzu I, Kutlay S, Nergizoglu G, Ates K. Renal amyloidosis secondary to hidradenitis suppurativa. Clinical Kidney Journal 2013; 6: 667–8.
  • 3.Montes-Romero JA, Callejas-Rubio JL, Sanchez-Cano D, Gonzalez-Martínez FJ, Navas-Parejo A, Ortego-Centeno N. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab. European Journal of Internal Medicine 2018; 19: 32–3.
  • 4.Fernandez-Nebro A, Alejandro O, Castro MC et al. Long-term TNFalfa blockade in patients with amyloid A amyloidosis complicating rheumatic diseases. The American Journal of Medicine 2010; 123: 454–61.
  • 5. Pinney JH, Smith CJ, Taube JB et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol 2013; 161: 525-32.
  • 6. Schandorff KD, Miller IM, Krustrup D, Jemec GB, Marckmann P. Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa. Clinical Nephrology 2016; 86: 51 –4.
  • 7. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. The New England journal of medicine 2007; 356: 2361-71.
  • 8. Castano A, Narotsky DL, Hamid N et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 2017; 38: 2879–87.
There are 8 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

İpek Büber

Mehmet Koray Adalı 0000-0002-0054-6252

Dursun Dursunoğlu

Samet Yılmaz

Publication Date December 30, 2020
Published in Issue Year 2020 Volume: 11 Issue: 5

Cite

APA Büber, İ., Adalı, M. K., Dursunoğlu, D., Yılmaz, S. (2020). Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa. Turkish Journal of Clinics and Laboratory, 11(5), 455-458. https://doi.org/10.18663/tjcl.737335
AMA Büber İ, Adalı MK, Dursunoğlu D, Yılmaz S. Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa. TJCL. December 2020;11(5):455-458. doi:10.18663/tjcl.737335
Chicago Büber, İpek, Mehmet Koray Adalı, Dursun Dursunoğlu, and Samet Yılmaz. “Nadir görülen Bir Restriktif Kardiyomiyopati Olgusu: Hidradenitis Suppurativa”. Turkish Journal of Clinics and Laboratory 11, no. 5 (December 2020): 455-58. https://doi.org/10.18663/tjcl.737335.
EndNote Büber İ, Adalı MK, Dursunoğlu D, Yılmaz S (December 1, 2020) Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa. Turkish Journal of Clinics and Laboratory 11 5 455–458.
IEEE İ. Büber, M. K. Adalı, D. Dursunoğlu, and S. Yılmaz, “Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa”, TJCL, vol. 11, no. 5, pp. 455–458, 2020, doi: 10.18663/tjcl.737335.
ISNAD Büber, İpek et al. “Nadir görülen Bir Restriktif Kardiyomiyopati Olgusu: Hidradenitis Suppurativa”. Turkish Journal of Clinics and Laboratory 11/5 (December 2020), 455-458. https://doi.org/10.18663/tjcl.737335.
JAMA Büber İ, Adalı MK, Dursunoğlu D, Yılmaz S. Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa. TJCL. 2020;11:455–458.
MLA Büber, İpek et al. “Nadir görülen Bir Restriktif Kardiyomiyopati Olgusu: Hidradenitis Suppurativa”. Turkish Journal of Clinics and Laboratory, vol. 11, no. 5, 2020, pp. 455-8, doi:10.18663/tjcl.737335.
Vancouver Büber İ, Adalı MK, Dursunoğlu D, Yılmaz S. Nadir görülen bir restriktif kardiyomiyopati olgusu: Hidradenitis suppurativa. TJCL. 2020;11(5):455-8.


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.